Phase 4 Hodgkin Lymphoma Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Eli Lilly and Company279 enrolled36 locationsNCT06876662
Recruiting
Phase 4
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Eli Lilly and Company787 enrolled38 locationsNCT06876649
Recruiting
Phase 4
A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India
Hodgkin Lymphoma
Takeda124 enrolled11 locationsNCT06831370
Recruiting
Phase 4
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
Acute Lymphoblastic LeukemiaNon-Hodgkin LymphomaAcute Myeloblastic Leukemia+1 more
Gadjah Mada University120 enrolled1 locationNCT07016165
Recruiting
Phase 4
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
Diffuse Large B Cell LymphomaPrimary CNS LymphomaBurkitt Lymphoma+2 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology300 enrolled1 locationNCT05518383
Not Yet Recruiting
Phase 4
A study of the safety and effectiveness of Lipegfilgrastim, a growth factor, to prevent fever and infections ('febrile neutropenia') in patients undergoing chemotherapy for Non-Hodgkin Lymphoma (NHLL)
Non-Hodgkin Lymphoma
Monash Health30 enrolled1 locationACTRN12618000055202